Akebia Therapeutics | AKBA - Current Liabilities


Akebia Therapeutics reported $162.35M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 332.22M 29.22M Sep/2026
Agios Pharmaceuticals USD 77.59M 7.37M Sep/2026
Akebia Therapeutics USD 162.35M 1.48M Sep/2026
Alnylam Pharmaceuticals USD 2.06B 550.49M Sep/2026
Amgen USD 23.23B 2.27B Sep/2026
Ardelyx USD 127.8M 4.42M Sep/2026
Astellas Pharma JPY 1.1T 134.96B Sep/2026
AstraZeneca USD 31.27B 286M Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
BioMarin Pharmaceutical USD 1.6B 59.17M Sep/2026
Celltrion KRW 288.01B 4.7B Jun/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Exelixis USD 411.88M 49.95M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
Ironwood Pharmaceuticals USD 34.73M 1.88M Sep/2026
J&J USD 55.46B 562M Sep/2026
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Karyopharm Therapeutics USD 117.3M 25.24M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Lexicon Pharmaceuticals USD 9.9M 10.97M Mar/2026
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 2.03B 506M Sep/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 107.28M 18.54M Jun/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pharma Mar EUR 125.39M 26.97M Sep/2026
Prothena USD 11.43M 224K Sep/2026
PTC Therapeutics USD 776.08M 5.01M Sep/2026
Qiagen NV USD 581.45M 102.34M Jun/2026
Regeneron Pharmaceuticals USD 6.2B 671.5M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026
Sarepta Therapeutics USD 656.35M 153.44M Sep/2026
Sartorius EUR 1.55B 102.8M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 10.37M 2.59M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
Vanda Pharmaceuticals USD 145.16M 27.29M Dec/2025
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.74B 277.02M Sep/2026